Selinexor Combinations in Clinical Trials with Dr. Jeffrey Zonder image

Selinexor Combinations in Clinical Trials with Dr. Jeffrey Zonder

Feb 15, 2022
07:00PM - 08:00PM EST
Online Event
Overview

What kind of success have we seen when using selinexor (XPOVIO) in different combinations? What is clinical trial data telling and us and what could the future of selinexor look like? Myeloma specialist Dr. Jeffrey Zonder will join us to discuss.

Agenda
07:00 PM
Introduction
Audrey Burton-Bethke
Audrey introduces the agenda of the event and featured speaker Dr. Jeffrey Zonder.
07:05 PM
Presentation
Dr. Jeffrey Zonder
Dr. Jeffrey Zonder talks about what kind of success we have seen when using selinexor (XPOVIO) in different combinations, what clinical trial data is telling us and what could the future of selinexor look like. 
07:35 PM
Questions and Answers
Audience
Type your questions in the chat and we will answer them! 
Speakers & Moderators
Healthtree contact Audrey Burton-Bethke

Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.
Healthtree contact Jeffrey Zonder, M.D.

Jeffrey Zonder, M.D.

Professor in the Departments of Oncology at the Barbara Ann Karmanos Cancer Institute (KCI) and Wayne State University School of Medicine. He is the leader of the KCI Multiple Myeloma and Amyloidosis Multidisciplinary Team and co-leader of Molecular Therapeutic Program. He is e member of the Steering Committee at the Multiple Myeloma Research Consortium, a medical advisor for the Amyloidosis Support Group Networks, and a member of the International Myeloma Working Group, the International Myeloma Society and the International Amyloidosis Society. He is a member of the Southwest Oncology Group’s (SWOG) Barlogie-Salmon Myeloma Committee. Dr. Zonder has authored or co-authored numerous original research papers, review articles, book chapters, and research abstracts on myeloma and amyloidosis. He completed a fellowship in hematology-oncology at Wayne State University and his medical residency at the University of Rochester, New York. He received his medical degree from Wayne State University School of Medicine.